Table of Content

1 Ertapenem Injection Market Overview
1.1 Product Overview and Scope of Ertapenem Injection
1.2 Ertapenem Injection Segment by Type
1.2.1 Global Ertapenem Injection Market Value Comparison by Type (2024-2034)
1.2.2 1g/Vial
1.2.3 Others
1.3 Ertapenem Injection Segment by Application
1.3.1 Global Ertapenem Injection Market Value by Application: (2024-2034)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Ertapenem Injection Market Size Estimates and Forecasts
1.4.1 Global Ertapenem Injection Revenue 2018-2029
1.4.2 Global Ertapenem Injection Sales 2018-2029
1.4.3 Global Ertapenem Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ertapenem Injection Market Competition by Manufacturers
2.1 Global Ertapenem Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Ertapenem Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Ertapenem Injection Average Price by Manufacturers (2018-2024)
2.4 Global Ertapenem Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Ertapenem Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ertapenem Injection, Product Type & Application
2.7 Ertapenem Injection Market Competitive Situation and Trends
2.7.1 Ertapenem Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ertapenem Injection Players Market Share by Revenue
2.7.3 Global Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ertapenem Injection Retrospective Market Scenario by Region
3.1 Global Ertapenem Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ertapenem Injection Global Ertapenem Injection Sales by Region: 2018-2029
3.2.1 Global Ertapenem Injection Sales by Region: 2018-2024
3.2.2 Global Ertapenem Injection Sales by Region: 2024-2029
3.3 Global Ertapenem Injection Global Ertapenem Injection Revenue by Region: 2018-2029
3.3.1 Global Ertapenem Injection Revenue by Region: 2018-2024
3.3.2 Global Ertapenem Injection Revenue by Region: 2024-2029
3.4 North America Ertapenem Injection Market Facts & Figures by Country
3.4.1 North America Ertapenem Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ertapenem Injection Sales by Country (2018-2029)
3.4.3 North America Ertapenem Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ertapenem Injection Market Facts & Figures by Country
3.5.1 Europe Ertapenem Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ertapenem Injection Sales by Country (2018-2029)
3.5.3 Europe Ertapenem Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ertapenem Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Ertapenem Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ertapenem Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Ertapenem Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ertapenem Injection Market Facts & Figures by Country
3.7.1 Latin America Ertapenem Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ertapenem Injection Sales by Country (2018-2029)
3.7.3 Latin America Ertapenem Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ertapenem Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ertapenem Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ertapenem Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ertapenem Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ertapenem Injection Sales by Type (2018-2029)
4.1.1 Global Ertapenem Injection Sales by Type (2018-2024)
4.1.2 Global Ertapenem Injection Sales by Type (2024-2029)
4.1.3 Global Ertapenem Injection Sales Market Share by Type (2018-2029)
4.2 Global Ertapenem Injection Revenue by Type (2018-2029)
4.2.1 Global Ertapenem Injection Revenue by Type (2018-2024)
4.2.2 Global Ertapenem Injection Revenue by Type (2024-2029)
4.2.3 Global Ertapenem Injection Revenue Market Share by Type (2018-2029)
4.3 Global Ertapenem Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Ertapenem Injection Sales by Application (2018-2029)
5.1.1 Global Ertapenem Injection Sales by Application (2018-2024)
5.1.2 Global Ertapenem Injection Sales by Application (2024-2029)
5.1.3 Global Ertapenem Injection Sales Market Share by Application (2018-2029)
5.2 Global Ertapenem Injection Revenue by Application (2018-2029)
5.2.1 Global Ertapenem Injection Revenue by Application (2018-2024)
5.2.2 Global Ertapenem Injection Revenue by Application (2024-2029)
5.2.3 Global Ertapenem Injection Revenue Market Share by Application (2018-2029)
5.3 Global Ertapenem Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Ertapenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Ertapenem Injection Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Endo
6.2.1 Endo Corporation Information
6.2.2 Endo Description and Business Overview
6.2.3 Endo Ertapenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Endo Ertapenem Injection Product Portfolio
6.2.5 Endo Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Aurobindo Pharma Ertapenem Injection Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 ACS Dobfar
6.4.1 ACS Dobfar Corporation Information
6.4.2 ACS Dobfar Description and Business Overview
6.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 ACS Dobfar Ertapenem Injection Product Portfolio
6.4.5 ACS Dobfar Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ertapenem Injection Industry Chain Analysis
7.2 Ertapenem Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ertapenem Injection Production Mode & Process
7.4 Ertapenem Injection Sales and Marketing
7.4.1 Ertapenem Injection Sales Channels
7.4.2 Ertapenem Injection Distributors
7.5 Ertapenem Injection Customers
8 Ertapenem Injection Market Dynamics
8.1 Ertapenem Injection Industry Trends
8.2 Ertapenem Injection Market Drivers
8.3 Ertapenem Injection Market Challenges
8.4 Ertapenem Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ertapenem Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ertapenem Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ertapenem Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ertapenem Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Ertapenem Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Ertapenem Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Ertapenem Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Ertapenem Injection Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Ertapenem Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Ertapenem Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ertapenem Injection, Product Type & Application
Table 12. Global Key Manufacturers of Ertapenem Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ertapenem Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ertapenem Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ertapenem Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ertapenem Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Ertapenem Injection Sales Market Share by Region (2018-2024)
Table 19. Global Ertapenem Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Ertapenem Injection Sales Market Share by Region (2024-2029)
Table 21. Global Ertapenem Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Ertapenem Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Ertapenem Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ertapenem Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Ertapenem Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ertapenem Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Ertapenem Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Ertapenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Ertapenem Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ertapenem Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ertapenem Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Ertapenem Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Ertapenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Ertapenem Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ertapenem Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ertapenem Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Ertapenem Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Ertapenem Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Ertapenem Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ertapenem Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ertapenem Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Ertapenem Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Ertapenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Ertapenem Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ertapenem Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ertapenem Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Ertapenem Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Ertapenem Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Ertapenem Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ertapenem Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Ertapenem Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Ertapenem Injection Sales Market Share by Type (2018-2024)
Table 53. Global Ertapenem Injection Sales Market Share by Type (2024-2029)
Table 54. Global Ertapenem Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Ertapenem Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ertapenem Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Ertapenem Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Ertapenem Injection Price (USD/Unit) by Type (2018-2024)
Table 59. Global Ertapenem Injection Price (USD/Unit) by Type (2024-2029)
Table 60. Global Ertapenem Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Ertapenem Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Ertapenem Injection Sales Market Share by Application (2018-2024)
Table 63. Global Ertapenem Injection Sales Market Share by Application (2024-2029)
Table 64. Global Ertapenem Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Ertapenem Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ertapenem Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Ertapenem Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Ertapenem Injection Price (USD/Unit) by Application (2018-2024)
Table 69. Global Ertapenem Injection Price (USD/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Ertapenem Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck Ertapenem Injection Product
Table 74. Merck Recent Developments/Updates
Table 75. Endo Corporation Information
Table 76. Endo Description and Business Overview
Table 77. Endo Ertapenem Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Endo Ertapenem Injection Product
Table 79. Endo Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Ertapenem Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Aurobindo Pharma Ertapenem Injection Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. ACS Dobfar Corporation Information
Table 86. ACS Dobfar Description and Business Overview
Table 87. ACS Dobfar Ertapenem Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. ACS Dobfar Ertapenem Injection Product
Table 89. ACS Dobfar Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Ertapenem Injection Distributors List
Table 93. Ertapenem Injection Customers List
Table 94. Ertapenem Injection Market Trends
Table 95. Ertapenem Injection Market Drivers
Table 96. Ertapenem Injection Market Challenges
Table 97. Ertapenem Injection Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ertapenem Injection
Figure 2. Global Ertapenem Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ertapenem Injection Market Share by Type in 2022 & 2029
Figure 4. 1g/Vial Product Picture
Figure 5. Others Product Picture
Figure 6. Global Ertapenem Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Ertapenem Injection Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Pediatric
Figure 10. Global Ertapenem Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Ertapenem Injection Market Size (2018-2029) & (US$ Million)
Figure 12. Global Ertapenem Injection Sales (2018-2029) & (K Units)
Figure 13. Global Ertapenem Injection Average Price (USD/Unit) & (2018-2029)
Figure 14. Ertapenem Injection Report Years Considered
Figure 15. Ertapenem Injection Sales Share by Manufacturers in 2022
Figure 16. Global Ertapenem Injection Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Ertapenem Injection Players: Market Share by Revenue in 2022
Figure 18. Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Ertapenem Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Ertapenem Injection Sales Market Share by Country (2018-2029)
Figure 21. North America Ertapenem Injection Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Ertapenem Injection Sales Market Share by Country (2018-2029)
Figure 25. Europe Ertapenem Injection Revenue Market Share by Country (2018-2029)
Figure 26. Germany Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Ertapenem Injection Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Ertapenem Injection Revenue Market Share by Region (2018-2029)
Figure 33. China Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Ertapenem Injection Sales Market Share by Country (2018-2029)
Figure 44. Latin America Ertapenem Injection Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Ertapenem Injection Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Ertapenem Injection Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Ertapenem Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Ertapenem Injection by Type (2018-2029)
Figure 54. Global Revenue Market Share of Ertapenem Injection by Type (2018-2029)
Figure 55. Global Ertapenem Injection Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Ertapenem Injection by Application (2018-2029)
Figure 57. Global Revenue Market Share of Ertapenem Injection by Application (2018-2029)
Figure 58. Global Ertapenem Injection Price (USD/Unit) by Application (2018-2029)
Figure 59. Ertapenem Injection Value Chain
Figure 60. Ertapenem Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed